Apprentice Regulatory Affairs, Global Regulatory Affairs Development Strategy

Updated: March 21, 2024 11:15 PM GMT

Full-time Job in Levallois-Perret, Ile-de-France

AstraZeneca

Levallois-Perret

Apprentice Regulatory Affairs, Global Regulatory Affairs Development Strategy

Reports to:

Senior Specialist Regulatory Affairs

Location:

Paris - Levallois-Perret

Alexion, Astrazeneca Rare Disease, is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic... More Detail